Moderna preparing to launch potential Covid-19 vaccine
Sat, 31 October 2020
Moderna Inc is “actively” preparing to launch its potential coronavirus vaccine mRNA-1273.
Meanwhile, Johnson & Johnson is planning to start testing its experimental Covid-19 vaccine among those aged 12 to 18 as soon as possible. Also, India announced on Friday that it will help all countries with vaccine and storage capacity.
Moderna CEO Stephane Bancel has said in a press release that the pharmaceutical company is preparing to launch its potential coronavirus vaccine mRNA-1273.
“We are actively preparing for the launch of mRNA-1273 and we have signed a number of supply agreements with governments around the world,” Moderna CEO Stephane Bancel was quoted by reports.
Last week, Moderna had completed enrollment for its 30,000-participant late-stage trial. Till then, more than 25,650 participants had received the second of the company’s two-dose Covid-19 vaccine. A report in CNBC had quoted Moderna as saying that about 37 per cent of the participants were from diverse communities and 42 per cent were at high risk of severe disease.
Moderna Inc had told Reuters that it would seek emergency FDA authorisation to use its vaccine in high-risk groups if an interim assessment of its trial showed its vaccine was at least 70 per cent effective.